Free Trial

Integrated BioPharma (INBP) Earnings Date, Estimates & Call Transcripts

Integrated BioPharma logo
$0.33 +0.00 (+0.03%)
As of 05/23/2025 01:23 PM Eastern

Integrated BioPharma Earnings Summary

Integrated BioPharma posted Q3 2025 earnings on May 14, 2025, reporting an EPS of $0.02. Quarterly revenue was reported to be $13.95 million. Integrated BioPharma currently has a trailing EPS of $0.04 and a P/E Ratio of 11.04

Q3 2025 Earnings Resources

Latest Q3 2025
Earnings Date
May. 14Estimated
Actual Revenue
(May. 14)
$13.95M
Get Integrated BioPharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Integrated BioPharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

INBP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INBP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Integrated BioPharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/14/2025Q3 2025-$0.02+$0.02$0.02-$13.95M
9/20/2024Q4 2024-$0.01+$0.01$0.01-$12.75M
5/10/2024Q3 2024-$0.01+$0.01$0.01-$13.15M
2/12/2024Q2 2024--$0.01 -$0.01-$0.01-$11.51M


This page (OTCMKTS:INBP) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners